Tate & Lyle plc Earnings Recaps
Q4 2026
May 22, 2026
Shares fell 2.7% following a disappointing earnings update marked by ongoing volume declines, muted demand, and weakness in key segments such as European bulk sweeteners and Latin American sweeteners. Despite completing the CP Kelco integration, management’s revised guidance and cautious outlook failed to reassure investors.
Key takeaways
- Revenue declined 3% on a like-for-like, constant currency basis due to volume pressures and softer market demand, consistent with prior revised guidance.
- Adjusted EBITDA fell 3% to GBP 415 million, driven by lower volumes and reinvestment in pricing, although partly offset by GBP 53 million in productivity gains.
- Bulk sweeteners in Europe accounted for about 20% of the revenue decline, weighed down by lower sugar pricing and fading demand.
- Latin America saw further weakness in sweetener volumes, notably in Mexico, contributing to about 30% of the top-line decline in the region.
- Asia Pacific showed resilience with stable revenue amid tariff challenges and a 9% increase in EBITDA, yet this was insufficient to offset softness elsewhere.
Q3 2026
Feb 26, 2026
Tate & Lyle's Q3 results met expectations, with reported revenue up 15% due to the acquisition of CP Kelco, while pro forma revenue showed a 2% decline amid muted demand across key regions.
Key takeaways
- Pro forma revenue decreased 2% year-over-year, reflecting ongoing muted market demand.
- Customer engagement is increasing, particularly with the fiber portfolio, driving potential for future revenue growth.
- The company is selectively investing in pricing to drive volume momentum, aligning with their goal of returning to top-line growth.
- Revenue synergies from the CP Kelco acquisition are in line with expectations, and cost synergies are projected to exceed $50 million by FY2027.
- The ongoing $200 million productivity program continues to deliver savings, supporting operational efficiency.